Dublin, Dec. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Polypropylene Nonwoven Fabric Market Size, Share & Trends Analysis Report by Product (Spunbonded, Staples), Application (Hygiene, Industrial), Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global polypropylene nonwoven fabric market is expected to reach USD 39.23 billion by 2028, registering a CAGR of 6.7% over the forecast period, according to the report.

Rising product demand in end-use industries including hygiene, medical, automotive, agriculture, and furnishing is anticipated to benefit the market growth over the forecast period. High product demand in the hygiene industry for manufacturing sanitary products for babies, women, and adults is likely to drive industry growth. In addition, rising innovation in the production of hygiene products developed to aid in discomfort, contamination, and odor by controlling microbial activity is boosting the product demand in hygiene applications. The market is experiencing trends, such as slow down of conventional petrochemical growth, private companies expanding their market share, major state-owned enterprises losing their market share, and rising demand from South and East Asia, which have a significant impact on the global market. Prominent players in the market are focusing on enhancements in business by expanding their geographical reach and introducing application-specified products. Mergers, acquisitions, joint ventures, and agreements are considered by these players to expand their portfolio and business reach, thereby benefiting the market growth over the forecast period. Market Highlights

The spun-bonded product segment accounted for the largest revenue share in 2020 and is projected to grow at a steady CAGR from 2021 to 2028. Excellent properties offered by spunbonded nonwoven fabrics coupled with high process efficiency associated with this technology is likely to drive the segment growth.

The medical application segment held the second-largest revenue share in 2020 and is expected to grow at a steady CAGR from 2021 to 2028. The segment growth is credited to the high product demand in applications, such as surgical caps, gowns, masks, drapes, bed linen, gloves, shrouds, underpads, heat packs, ostomy bag liners, and incubator mattress.

Asia Pacific was the largest regional market in 2020 and is estimated to grow at a significant CAGR from 2021 to 2028. The growing demand for durable polypropylene non-woven fabrics in industries, such as construction, agriculture, and automobile, is anticipated to drive the APAC regional market growth.

High production capacities, extensive distribution network, and goodwill in the market are the key factors that offer a competitive advantage for the multinationals in this business.

For more information about this report visit https://www.researchandmarkets.com/r/cfnecm

Our call of the day says investors have been selling high-beta names too hard, because they're about to enter their biggest month.

As we get ready to turn the page on 2021, I can't help but note how we've witnessed a pretty substantial market bifurcation in stocks over the past couple of quarters. Below are four stocks that I believe are likely to find their way into my portfolio in 2022. A year ago, I was completely against electric vehicle (EV) manufacturer Nio (NYSE: NIO).

Shares of Microbot Medical Inc. rocketed 67.3% toward a nine-month high on heavy volume in premarket trading Monday, after the pre-clinical medical device company announced an agreement with Stryker Corp. to develop the first dedicated robotic procedural kits for use in certain neurovascular procedures. Trading volume ballooned to 9.6 million shares, compared with the full-day average of about 49,000 shares. The stock was the biggest gainer and most actively traded ahead of the open. As part of

Web 3.0 is widely considered to be the next frontier of internet technology, making the metaverse a golden macrotrend for retail investors. The metaverse refers to an easily scalable real-time virtual reality or mixed reality world, comprising several interoperable, immersive, and interactive 3D environments. The metaverse is also expected to maintain all relevant information about payments, identity, and history across user sessions.

Nvidia is up 130% this year and trades at lofty multiples. But there are a few chip stocks that still look cheap on a price-to-earnings basis.

Investing in stocks can be a risky endeavor. Buying a stock does not guarantee an investor a return on that investment. For that matter, it does not even guarantee an investor a return of their initial investment.

The dividends for such stocks are pretty much their only attraction. On the other hand, you can find dividend stocks that are anything but boring and stodgy. Here are three dividend stocks that soared more than 50% in 2021 and are still great buys.

Abbott Laboratories (NYSE: ABT) shares have gained around 26% in 2021. Despite the big payout bumps, Abbott only needed around 33% of the free cash flow its operations generated over the past year to make dividend payments. Despite pandemic pressure, medical-device segment sales during the first nine months of 2021 rose 24.5% year over year to $10.6 billion.

Dow Jones futures rose 50 points Monday, as the stock market looked to extend a win streak. Tesla stock is nearing a new buy point.

Wall Street's consensus price target for Teladoc Health (NYSE: TDOC) stock over the next 12 months reflects a 67% upside potential. It's quite possible that the spread of the omicron variant of COVID-19 could give Teladoc a boost in the near term. Teladoc enjoyed a big surge in virtual visits in 2020 thanks to the pandemic.

The company, which is sparing its executives from the cut, says it brings benefits in line with what other firms offer. One retiree: ‘If there isn’t a legal obligation, there certainly is a moral obligation.’

When looking for the best artificial intelligence stocks to buy, identify companies using AI technology to improve products or gain a strategic edge, such as Google, Microsoft and Nvidia.

For retail investors, seeking solid clues to the probable movements of the equity markets, the great volume of published analysis from the Wall Street experts is a blessing, making available everything the investor needs to know to trade successfully. But it comes with a price. The sheer quantity of data involved is almost impossible for the non-expert to parse, but how to know which of the 7,700 stock pros is the best to listen to? A look at the Top Wall Street Analysts ratings from TipRanks ca

(Bloomberg) -- There’s no reason to fear that the rally that catapulted U.S. stocks to successive records this year will end anytime soon, according to JPMorgan Chase & Co. strategists. In fact, more investors may soon join. Most Read from BloombergCoronavirus Can Persist for Months After Traversing BodyU.S. Futures Rise as Traders Mull Virus, China Vow: Markets WrapCases Surge Globally; Fauci Warns of Complacency: Virus UpdateTrudeau Says China Playing Western States Against Each OtherSingapore

Banks are healthy, but their catalysts for growth are murky. These half-dozen stocks rise above the pack, says one strategist.

Naren Gupta, a venture capitalist who co-founded Nexus Venture Partners to help plant Indian SaaS startups on the world map, died on Saturday. Gupta, who moved to the U.S. to pursue higher education in late 1960s, co-founded Integrated Systems, a software firm that was ultimately sold to Intel. After leaving the firm, he began to explore investment opportunities.

'Rich Dad Poor Dad' is as bearish as ever.

One of the best ways to put money to work in the stock market over the long run is to buy best-of-breed companies. The not-so-subtle secret to CrowdStrike's success is the company's cloud-native platform known as Falcon. CrowdStrike notes that Falcon oversees about 1 trillion events each day.

Shares were trending downward in pre-market trading Monday as South Florida-based cruise companies confirmed more onboard Covid-19 outbreaks over the holiday weekend.

We’re about to turn the page on the calendar, put 2021 behind us, and stride into the brave, new year of 2022 – and Wall Street’s prognosticators are busy scanning the stocks to find the winners and losers for next year’s markets. Whether it’s individual stocks, whole industry sectors, or some combination of both, the analysts are finding plenty of Buy-rated equities for investors to consider. Take the automotive sector. Few industrials will present as many investment opportunities, both in 2022